Evidence map›Paper›PMID 27907120›Full record

ArticlePloS one2016

Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals.

Joel D A Tyndall, Manya Sabherwal, Alia A Sagatova, Mikhail V Keniya, Jacopo Negroni, Rajni K Wilson, Matthew A Woods, Klaus Tietjen, Brian C Monk

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. New thymol-derived triazole exhibits promising activity against Trichophyton rubrum.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  10. Article
  11. Article
  12. Synthesis, antimicrobial activity and molecular docking study of benzyl functionalized benzimidazole silver(I) complexes.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2023
    Article
  13. Article
  14. Article
  15. Characterisation ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Joel D A TyndallNew Zealand's National School of Pharmacy, University of Otago, Dunedin, New Zealand.ORCID http://orcid.org/0000-0003-0783-1635
Manya SabherwalSir John Walsh Research Institute, New Zealand's National Centre for Dentistry, University of Otago, Dunedin, New Zealand.
Alia A SagatovaSir John Walsh Research Institute, New Zealand's National Centre for Dentistry, University of Otago, Dunedin, New Zealand.
Mikhail V KeniyaSir John Walsh Research Institute, New Zealand's National Centre for Dentistry, University of Otago, Dunedin, New Zealand.
Jacopo NegroniBayer SAS, Division Crop Science, Disease Control Research, Lyon, France.
Rajni K WilsonSir John Walsh Research Institute, New Zealand's National Centre for Dentistry, University of Otago, Dunedin, New Zealand.
Matthew A WoodsSir John Walsh Research Institute, New Zealand's National Centre for Dentistry, University of Otago, Dunedin, New Zealand.
Klaus TietjenBayer AG, Division Crop Science, Disease Control Research, Monheim, Germany.ORCID http://orcid.org/0000-0002-8199-9180
Brian C MonkSir John Walsh Research Institute, New Zealand's National Centre for Dentistry, University of Otago, Dunedin, New Zealand.
University of Otago · NZBayer (France) · FRBayer (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azole antifungals, known as demethylase inhibitors (DMIs), target sterol 14α-demethylase (CYP51) in the ergosterol biosynthetic pathway of fungal pathogens of both plants and humans. DMIs remain the treatment of choice in crop protection against a wide range of fungal phytopathogens that have the potential to reduce crop yields and threaten food security. We used a yeast membrane protein expression system to overexpress recombinant hexahistidine-tagged S. cerevisiae lanosterol 14α-demethylase and the Y140F or Y140H mutants of this enzyme as surrogates in order characterize interactions with DMIs. The whole-cell antifungal activity (MIC50 values) of both the R- and S-enantiomers of tebuconazole, prothioconazole (PTZ), prothioconazole-desthio, and oxo-prothioconazole (oxo-PTZ) as well as for fluquinconazole, prochloraz and a racemic mixture of difenoconazole were determined. In vitro binding studies with the affinity purified enzyme were used to show tight type II binding to the yeast enzyme for all compounds tested except PTZ and oxo-PTZ. High resolution X-ray crystal structures of ScErg11p6×His in complex with seven DMIs, including four enantiomers, reveal triazole-mediated coordination of all compounds and the specific orientation of compounds within the relatively hydrophobic binding site. Comparison with CYP51 structures from fungal pathogens including Candida albicans, Candida glabrata and Aspergillus fumigatus provides strong evidence for a highly conserved CYP51 structure including the drug binding site. The structures obtained using S. cerevisiae lanosterol 14α-demethylase in complex with these agrochemicals provide the basis for understanding the impact of mutations on azole susceptibility and a platform for the structure-directed design of the next-generation of DMIs.

Indexed as

14-alpha Demethylase InhibitorsAgrochemicalsAntifungal AgentsAzolesBinding SitesCatalytic DomainMicrobial Sensitivity TestsMolecular ConformationMolecular StructureProtein BindingSaccharomyces cerevisiaeSterol 14-DemethylaseStructure-Activity RelationshipSubstrate SpecificityYeasts14-alpha Demethylase InhibitorsAgrochemicalsAntifungal AgentsAzolesSterol 14-Demethylase

Identifiers

PMID27907120
PMCPMC5132298
OpenAlexW2557500900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.